Jump to content

Susan Band Horwitz

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rjwilmsi (talk | contribs) at 09:51, 2 November 2014 (→References: Journal cites, added 1 PMID, added 1 PMC using AWB (10482)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Susan Band Horwitz is an American biochemist and professor at the Albert Einstein College of Medicine. She studies molecular pharmacology, focusing on the mechanisms by which anti-tumor drugs work and the mechanisms of drug resistance. Her award-winning work starting in the 1970s on paclitaxel revealed that the way it inhibited cell division was by binding to microtubules. As a result, this compound was developed into a common treatment for ovarian, breast and non-small cell lung cancers.

References

  • "The Honorable Edward M. Kennedy, Mina J. Bissell, Susan Band Horwitz, and Jon M. Huntsman to Receive American Cancer Society Highest Honor". November 21, 2008.
  • Davis, Tinsley H. "Profile of Susan Band Horwitz". Proc. Nat. Acad. Sci. 103 (27): 10163–10165. doi:10.1073/pnas.0604639103. PMC 1502428. PMID 16801530.


Flag of United StatesScientist icon

This article about an American biochemist is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Susan_Band_Horwitz&oldid=632120132"